Detalles de la búsqueda
1.
A phase 3 trial of azacitidine versus a semi-intensive fludarabine and cytarabine schedule in older patients with untreated acute myeloid leukemia.
Cancer
; 127(12): 2003-2014, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33626197
2.
Defibrotide in hematopoietic stem cell transplantation: A multicenter survey study of the Spanish Hematopoietic Stem Cell Transplantation Group (GETH).
Eur J Haematol
; 106(6): 842-850, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33713387
3.
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA Group.
Cancer
; 125(16): 2810-2817, 2019 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31012967
4.
Transcriptional and genomic characterization of measurable residual disease in acute myeloid leukaemia.
Br J Haematol
; 201(6): 1239-1244, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37057357
5.
Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry.
Ann Hematol
; 96(10): 1727-1733, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28748287
6.
Clinical characteristics of patients with central nervous system relapse in BCR-ABL1-positive acute lymphoblastic leukemia: the importance of characterizing ABL1 mutations in cerebrospinal fluid.
Ann Hematol
; 96(7): 1069-1075, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28451802
7.
Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients.
Ann Hematol
; 93(2): 299-307, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23995612
8.
Azacitidine vs. Decitabine in Unfit Newly Diagnosed Acute Myeloid Leukemia Patients: Results from the PETHEMA Registry.
Cancers (Basel)
; 14(9)2022 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565471
9.
Real-world effectiveness of caplacizumab vs the standard of care in immune thrombotic thrombocytopenic purpura.
Blood Adv
; 6(24): 6219-6227, 2022 12 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930694
10.
The Mutational Landscape of Acute Myeloid Leukaemia Predicts Responses and Outcomes in Elderly Patients from the PETHEMA-FLUGAZA Phase 3 Clinical Trial.
Cancers (Basel)
; 13(10)2021 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-34070172
11.
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trial.
Blood Adv
; 5(3): 760-770, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33560390
12.
Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience.
Clin Lymphoma Myeloma Leuk
; 21(6): 413-420, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33741302
13.
Treatment of Frail Older Adults and Elderly Patients With Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia: Results of a Prospective Trial With Minimal Chemotherapy.
Clin Lymphoma Myeloma Leuk
; 20(8): e513-e522, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32336676
14.
A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.
Leuk Res
; 76: 1-10, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30468991
15.
Frequency and prognostic significance of additional cytogenetic abnormalities to the Philadelphia chromosome in young and older adults with acute lymphoblastic leukemia.
Leuk Lymphoma
; 59(1): 146-154, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28554259
16.
Lack of negative impact of Philadelphia chromosome in older patients with acute lymphoblastic leukaemia in the thyrosine kinase inhibitor era: comparison of two prospective parallel protocols.
Br J Haematol
; 159(4): 485-8, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22966847
17.
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group.
Leuk Res
; 41: 12-20, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686475
18.
Differences in anti-apoptotic and multidrug resistance phenotypes in elderly and young acute myeloid leukemia patients are related to the maturation of blast cells.
Haematologica
; 90(1): 54-9, 2005 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-15642669
19.
CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Clin Cancer Res
; 10(22): 7599-606, 2004 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15569991
20.
Pharmacological profiles of acute myeloid leukemia treatments in patient samples by automated flow cytometry: a bridge to individualized medicine.
Clin Lymphoma Myeloma Leuk
; 14(4): 305-18, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24468131
Resultados
1 -
20
de 20
1
Próxima >
>>